Logo

Epigenomics: Andrew Lukowiak

May 19, 2023

Epigenomics said that Andrew Lukowiak has resigned from his position of president and CSO, and as a member of the executive board, effective May 31. Lukowiak has held these positions since December 2021. The company said that his resignation is in accord with a company restructuring initiated on Feb. 15, 2023, in the wake of the company failing to raise additional capital for a pivotal study to support US Food and Drug Administration approval of its colorectal cancer screening assay.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.